MARATTO

article · Virology Journal

Phage vB_AbaM_MU1 for biocontrol of carbapenem-resistant Acinetobacter baumannii (CRAB) isolated from wound infection

2026Open accessMansoura University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

These findings provide a strong, well-justified foundation for considering vB_AbaM_MU1 phage as successful candidate for phage therapy in treating CRAB- induced wound infections.

Research topics

  • Bacteriophages and microbial interactions
  • Antibiotic Resistance in Bacteria
  • Monoclonal and Polyclonal Antibodies Research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1186/s12985-026-03066-9

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.